This statistic shows the global spending on diabetes in developed and so called pharmerging markets from 2013 to 2018. In 2013, the developed diabetes market expended 35 billion U.S. dollars. Among others, growth in spending is driven by the increasing price of modern insulin in the United States. In developed markets, new therapies targeting diabetes is a significant driver of market growth.
Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
The statistic is available in another language. Switch language.
Print the statistic including description and metadata.
Chart type
Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
* Developed: U.S., Japan, Germany, France, Italy, Spain, U.K., Canada, South Korea. Pharmerging: China, Brazil, Russia, India, Algeria, Argentina, Colombia, Egypt,
Indonesia, Mexico, Nigeria, Pakistan, Poland, Romania, Saudi Arabia, South Africa, Thailand, Turkey, Ukraine, Venezuela, Vietnam. Class forecasts adapted from
IMS Market Prognosis September 2014. Spending in US$ with variable exchange rates. Growth in US$ at constant exchange rates.
Learn more about how Statista can support your business.
IMS Health (Institute for Healthcare Informatics). (November 24, 2014). Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)* [Graph]. In Statista. Retrieved May 14, 2025, from https://www.statista.com/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics). "Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*." Chart. November 24, 2014. Statista. Accessed May 14, 2025. https://www.statista.com/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics). (2014). Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: May 14, 2025. https://www.statista.com/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics). "Diabetes Spending in Developed and Pharmerging Markets from 2013 to 2018 (in Billion U.S. Dollars)*." Statista, Statista Inc., 24 Nov 2014, https://www.statista.com/statistics/373981/global-spending-on-diabetes-by-market/
IMS Health (Institute for Healthcare Informatics), Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/373981/global-spending-on-diabetes-by-market/ (last visited May 14, 2025)
Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)* [Graph], IMS Health (Institute for Healthcare Informatics), November 24, 2014. [Online]. Available: https://www.statista.com/statistics/373981/global-spending-on-diabetes-by-market/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
